Open Access

AI-2-dependent gene regulation in Staphylococcus epidermidis

  • Min Li1,
  • Amer E Villaruz1,
  • Viveka Vadyvaloo1, 3,
  • Daniel E Sturdevant2 and
  • Michael Otto1Email author
BMC Microbiology20088:4

https://doi.org/10.1186/1471-2180-8-4

Received: 25 October 2007

Accepted: 08 January 2008

Published: 08 January 2008

Abstract

Background

Autoinducer 2 (AI-2), a widespread by-product of the LuxS-catalyzed S-ribosylhomocysteine cleavage reaction in the activated methyl cycle, has been suggested to serve as an intra- and interspecies signaling molecule, but in many bacteria AI-2 control of gene expression is not completely understood. Particularly, we have a lack of knowledge about AI-2 signaling in the important human pathogens Staphylococcus aureus and S. epidermidis.

Results

To determine the role of LuxS and AI-2 in S. epidermidis, we analyzed genome-wide changes in gene expression in an S. epidermidis luxS mutant and after addition of AI-2 synthesized by over-expressed S. epidermidis Pfs and LuxS enzymes. Genes under AI-2 control included mostly genes involved in sugar, nucleotide, amino acid, and nitrogen metabolism, but also virulence-associated genes coding for lipase and bacterial apoptosis proteins. In addition, we demonstrate by liquid chromatography/mass-spectrometry of culture filtrates that the pro-inflammatory phenol-soluble modulin (PSM) peptides, key virulence factors of S. epidermidis, are under luxS/AI-2 control.

Conclusion

Our results provide a detailed molecular basis for the role of LuxS in S. epidermidis virulence and suggest a signaling function for AI-2 in this bacterium.

Background

Quorum sensing is the cell population density-dependent regulation of gene expression by small signaling molecules, called autoinducers (AI) [1]. Many bacteria have several quorum sensing systems. For example, in the extensively studied Vibrio harveyi, there are two classes of quorum-sensing systems, one of which utilizes an acylhomoserine lactone as signal (AI-1), and the other a signal molecule commonly referred to as AI-2 [2]. The biochemical synthesis of AI-2 involves several enzymatic steps starting from S-adenosylmethionine (SAM), particularly that catalyzed by LuxS, which produces AI-2 as a side product in addition to the primary role of this enzyme in the activated methyl cycle metabolism [3].

Most quorum-sensing autoinducers are specific for a narrow range of organisms and promote intra-species communication. In contrast, the widely conserved AI-2 has been proposed to allow for communication between species [4]. In fact, more than 55 bacterial species are known to possess a gene homologous to luxS, and many produce AI-2 like activities [5]. Since the discovery of AI-2 in V. harveyi, many organisms have been shown to regulate genes specifying diverse functions in a luxS-dependent manner, such as virulence factors in Streptococcus pneumoniae [6], E. coli (EHEC) O157:H7 [7], and Streptococcus pyogenes [8]; motility in Campylobacter jejuni [9], and biofilm formation in Streptococcus gordonii [10], E. coli K-12 [11], Bacillus cereus [12], Streptococcus mutans [13], and Klebsiella pneumonia [14]. However, the function of AI-2 in most bacteria is not completely understood, owing to the fact that distinguishing between a genuine signal and a mere role as a metabolic side product is difficult [15]. Clear evidence for a signal function can be derived from the discovery of AI-2-specific sensor/regulator systems and transporters. In V. harveyi, AI-2 is detected by a two-component system called LuxP/LuxQ [16, 17], whose AI-2 dependent activation results in the modulation of gene transcription. However, LuxP homologues are found only in Vibrio [18]. In non-Vibrio species, the only genes shown to be directly regulated by AI-2 encode an ABC transporter in Salmonella enterica serovar Typhimurium named Lsr, which in that species is responsible for AI-2 uptake [19, 20].

Staphylococcus epidermidis is the most frequent cause of nosocomial sepsis and catheter-related infection [21]. S. epidermidis has one well-characterized quorum-sensing system termed agr for accessory gene regulator [22, 23]. Additionally, like many other bacteria, S. epidermidis contains a luxS gene and produces AI-2 [24]. In S. aureus, inactivation of luxS strains does not affect virulence-associated traits, such as the production of hemolysins and extracellular proteases, biofilm formation, and the agr system [25]. In contrast, S. epidermidis luxS has been shown to influence biofilm formation in vitro and enhance virulence in a rat model of biofilm-associated infection [24]. However, whether AI-2 functions as a signaling molecule in staphylococci has remained a matter of debate, mostly because evidence was only derived from the comparison of luxS mutants with the corresponding wild-type strains, and sensors or transporters for AI-2 in Staphylococcus species are not known. Therefore, to gain further insight into the role of AI-2 in staphylococci, and specifically in S. epidermidis, we synthesized AI-2 using S. epidermidis Pfs and LuxS enzymes and analyzed AI-2-dependent gene regulation using transcriptional profiling in wild-type, luxS mutant, and luxS mutant strain with exogenous addition of AI-2. AI-2 regulated genes included genes involved in glycol-, nucleotide, amino acid, and nitrogen metabolism, but also virulence-associated genes coding for the pro-inflammatory PSM peptides, lipase, and the bacterial apoptosis Lrg proteins. Our study suggests that AI-2 has a signaling function in S. epidermidis and an important role in the control of metabolism and virulence.

Results

Characterization of the S. epidermidis luxS mutant

First, the isogenic luxS mutant strain of strain S. epidermidis 1457 was characterized for growth and AI-2 production under the conditions used for the subsequent gene expression experiments. As expected, no AI-2 could be detected in the isogenic luxS mutant strain, grown in TSB without glucose or TSB with 0.5% glucose (Fig. 1A). In the wild-type strain, AI-2 activity peaked during exponential growth phase and declined during stationary phase. Further, deletion of luxS did not affect growth of S. epidermidis 1457, indicating that its role in metabolism is not essential for bacterial growth under the tested nutrient-rich conditions (Fig. 1B).
Figure 1

(A) Detection of AI-2 activity during growth of S. epidermidis 1457 and S. epidermidis 1457ΔluxS. Every hour, cell-free supernatants were examined for the capacity to induce light production in V. harveyi BB170. Data were obtained from at least three independent experiments and normalized against light production in TSB or TSB/0.5% glucose. (B) Growth of S. epidermidis 1457 and S. epidermidis 1457ΔluxS in TSB with different concentration of glucose. Overnight cultures were 1:100 diluted in TSB without glucose or TSB supplemented with 0.5% glucose and the OD600 nm during growth of the main cultures was determined. (C) AI-2 activity during incubation with S. epidermidis 1457ΔluxS and in media controls. AI-2 was added to cells of S. epidermidis 1457ΔluxS at exponential growth phase in TSB without glucose and TSB with 0.5% glucose. The same quantity of AI-2 was added to the cell-free culture as control. Afterwards, every hour 1 ml of cell-free supernatant was collected for the detection of AI-2 activity.

In vitro production of AI-2 by purified Pfs and LuxS and luxS-independent removal of AI-2 from cultures

For complementation of AI-2 dependent signaling in the luxS mutant strain by external addition of AI-2, GST-Pfs and 6His-LuxS were used to synthesize AI-2 from S-adenosylhomocysteine (SAH). Most of His-tag-LuxS was soluble using standard conditions. To obtain soluble GST-Pfs, a low concentration of IPTG was used (0.25 mM), and cultures were grown at low temperature (25°C). Protein functionality was tested via AI-2 production using the V. harveyi BB170 bioassay, and induction of the reporter strain was determined as described before (Table 1).
Table 1

In vitro AI-2 production from SAH using purified proteins

Substrate

Protein

Normalized fold induction

SAH

None

1

SAH

Pfs

7

SAH

LuxS

12

SAH

Pfs+LuxS

29200

SAH

Pfs+LuxS (filtered)1

28700

1 reactions were filtered to remove protein

AI-2 can be removed from culture supernatants in a luxS-independent manner, as shown in Pseudomonas fluorescens [3], which does not have luxS. Similarly, we found that the S. epidermidis luxS mutant strain had the capacity to remove AI-2 activity from culture supernatants, while AI-2 in controls was stable over the same period of time (Fig. 1C). It is not clear at this point whether the removal of AI-2 is due to it being metabolized or imported for signaling purposes.

AI-2 dependent gene regulation in S. epidermidis

Genome-wide transcriptional profiling with DNA microarrays was used to determine (i) the luxS regulon in S. epidermidis 1457 and (ii) the extent to which addition of synthetic AI-2 complements alterations in gene expression in the luxS mutant (Table 2). We used 2-fold alteration as a cutoff. Most of the AI-2 regulated genes were involved in sugar, nucleotide, amino acid, and nitrogen metabolism, but AI-2 also regulated virulence-associated factors such as lipase, phenol-soluble modulins (PSMs) and the bacterial apoptosis protein LrgB. Furthermore, we observed much stronger changes in gene expression when using TSB without glucose, while the addition of 0.5% glucose in general had similar, but much reduced effects (data not shown). These results may indicate that the metabolic role of luxS is more important under nutrient limitation, consistent with results achieved in S. aureus, where reduced growth was only found under strong nutrient limitation in sulfur-limited defined media [25].
Table 2

Gene regulatory responses in S. epidermidis wild-type, ΔluxS and ΔluxS with exogenous AI-2

Gene number

Gene product

ΔluxS/WT

ΔluxS+ AI-2/ΔluxS

 

Glycometabolism

  

SE0164

Hexose phosphate transport protein

0.46

4.82

SE1219

Truncated transposase

2.41

0.44

SERP1353

Phosphoenolpyruvate carboxykinase

0.3

6.43

SERP1791

PTS system, lactose-specific IIA component

0.52

2.15

SERP1792

Tagatose 1,6-diphosphate aldolase

0.45

2.23

SERP1793

Tagatose-6-phosphate kinase

0.41

2.47

SERP1794

Galactose-6-phosphate isomerase

0.4

2.45

SERP1795

Galactose-6-phosphate isomerase

0.42

2.48

SERP1909

PTS system, IIBC components

0.37

3.88

SERP2057

Gluconate transporter, permease protein

0.48

3.94

SERP2058

Gluconokinase

0.33

6.43

SERP2059

Gluconate operon transcriptional repressor

0.37

6.03

SERP2100

Ribokinase

0.49

2.71

SERP2101

Ribose transport protein

0.42

3.14

SERP2260

PTS system, fructose-specific IIABC components

0.29

8.11

SERP2261

Mannose-6-phosphate isomerase

0.34

5.9

SERP2312

Malate:quinone oxidoreductase

2.64

0.33

 

Nucleotide metabolism

  

SERP0067

Xanthine phosphoribosyltransferase

3.17

0.4

SERP0068

Xanthine permease

3.35

0.39

SERP0652

Phosphoribosylformylglycinamidine synthase, PurS protein

3.65

0.45

SERP0653

Phosphoribosylformylglycinamidine synthase I

3.84

0.37

SERP0654

Phosphoribosylformylglycinamidine synthase II

3.17

0.4

SERP0655

Amidophosphoribosyltransferase

3.68

0.26

SERP0656

Phosphoribosylaminoimidazole synthetase

2.62

0.33

SERP0657

Phosphoribosylglycinamide formyltransferase

2.52

0.35

SERP0658

Phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase

2.45

0.34

SERP0659

Phosphoribosylamine – glycine ligase

2.21

0.42

 

Amino acid metabolism

  

SERP2128

Delta-1-pyrroline-5-carboxylate dehydrogenase, putative

0.42

3.2

SERP2327

Acetoin dehydrogenase, E3 component, dihydrolipoamide dehydrogenase

0.49

6.18

SERP2326

Acetoin dehydrogenase, E1 component, alpha subunit

0.44

5.24

SERP2325

Acetoin dehydrogenase, E1 component, beta subunit

0.53

4.95

 

Nitrogen metabolism

  

SERP1980

Nitrite extrusion protein

3.16

0.28

SERP1984

Respiratory nitrate reductase, gamma subunit

2.57

0.47

SERP1985

Respiratory nitrate reductase, delta subunit

4.81

0.39

SERP1986

Respiratory nitrate reductase, beta subunit

3.93

0.47

SERP1989

Nitrite reductase

2.52

0.46

 

Other

  

SERP0878

Portal protein, truncation

3.76

0.48

SERP2027

Antiholin-like protein LrgB

0.46

9.38

SERP2069

Major facilitator superfamily protein

0.5

2.36

SERP2222

Transcriptional regulator CadC

2.09

0.48

 

Unclassified

  

SERP0895

Hypothetical protein

0.36

3.53

SERP1923

Hypothetical protein

2.27

0.43

SERP2068

Hypothetical protein

0.45

3.99

SERP2102

Hypothetical protein

0.37

3.84

SERP2333

Hypothetical protein

0.53

2.55

To verify our microarray data, we performed real-time RT-PCR on a selected number of the identified AI-2 regulated genes (Fig. 2), which gave results consistent with those achieved using the microarrays. Further, not all PSM genes are included in the DNA microarray owing to their short gene lengths. Therefore, we quantified PSMs in bacterial culture supernatants by HPLC-MS to confirm the impact of luxS on the expression of PSM genes (Fig. 3). PSM levels were significantly reduced in the supernatants of the ΔluxS strain compared to those obtained from the wild-type strain, and production was restored after addition of synthesized AI-2. These results demonstrate that AI-2 signaling has a very significant impact on PSMs, which represent one of the most important virulence factors of S. epidermidis with involvement in both biofilm formation and inflammation [2628].
Figure 2

Quantitative RT-PCR of selected luxS/AI-2 regulated genes. Growth conditions of cultures in which relative transcription levels were determined were the same as in the microarray experiments. *, p < 0.05, **, p < 0.01, ***, p < 0.001. Comparisons are vs. wild type for ΔluxS and vs. ΔluxS for ΔluxS + AI-2.

Figure 3

Relative production of major PSMs in wild-type, ΔluxS, and ΔluxS strain with AI-2 addition. **, p < 0.01, ***, p < 0.001. Data are from the integration of extracted ion chromatograms of the two major peptide peaks produced in electrospray mass chromatograms of culture filtrates using HPLC/MS. Comparisons are vs. wild type for ΔluxS and vs. ΔluxS for ΔluxS + AI-2. No statistical analysis could be performed for PSM beta1 as there were no detectable levels of PSM beta1 in the ΔluxS strain.

Discussion

In recent years, the skin commensal microorganism S. epidermidis, has emerged as a leading cause of hospital-acquired infections [29]. S. epidermidis infections are primarily associated with the use of medical devices such as venous catheters. Many regulatory systems control virulence-associated traits in S. epidermidis [30]. Specifically, we have recently reported that a luxS mutant strain of S. epidermidis showed increased biofilm formation in vitro and enhanced virulence in a rat model of biofilm-associated infection [24]. On the contrary, inactivation of luxS in various S. aureus strains has been reported not to affect virulence-associated traits [25]. In further contrast to S. aureus, we show here that AI-2 activity in S. epidermidis was not maintained in stationary growth phase, but quickly decreased after obtaining a maximum during exponential growth. Thus, the role of AI-2 in staphylococci remains a matter of debate and there might be species-specific differences.

To gain further insight into luxS-dependent gene regulation and AI-2-dependent signaling in S. epidermidis, we used genome-wide transcriptional profiling. We synthesized AI-2 with over-expressed S. epidermidis enzymes and used the synthesized AI-2 in transcriptional profiling experiments to validate the signal role of AI-2. As main results of our studies, we detected that (i) externally added AI-2 almost completely restored gene expression patterns of the wild-type strain in the luxS mutant strain and (ii) S. epidermidis regulates virulence-associated factors in addition to metabolism in an AI-2-dependent fashion. Importantly, there was dramatic AI-2-dependent alteration of PSM expression. PSMs have been recently recognized as key pro-inflammatory and immune evasion factors in S. epidermidis and S. aureus [27, 28, 31] and very likely have an additional function in biofilm development [26]. Further, we did not observe any influence of luxS on agr, a quorum-sensing system with a pronounced regulatory effect on PSM expression [28, 31] and therefore, luxS-dependent regulation of PSMs occurs via a yet undiscovered pathway. Moreover, we observed AI-2-dependent regulation of the antiholin protein LrgB, a possible main player in induced cell death in bacteria and DNA-dependent bacterial biofilm formation [32, 33]. Interestingly, we did not find the ica genes coding for production of the biofilm exopolysaccharide PIA among the genes regulated by AI-2 under the conditions used (during exponential growth at high activity of AI-2), which contrasts our previous findings that demonstrated luxS-dependent control of ica during later growth stages [24], when AI-2 activity is low. These findings may suggest that expression of the ica genes is impacted by the metabolic function of LuxS rather than AI-2 control, a hypothesis that remains to be validated.

Conclusion

Our results indicate important species-specific differences in luxS-dependent gene regulation between S. epidermidis and S. aureus. Further, based on the complementation with synthesized AI-2 and the inclusion of virulence genes in the luxS regulon, our study suggests that AI-2 has a signaling function in S. epidermidis. However, AI-2 signaling in staphylococci needs to be confirmed on a molecular level showing how AI-2 interacts with an external sensor, or alternatively, is imported into the cell for an internal sensor mechanism.

Methods

Bacterial strains and growth conditions

The bacteria and plasmids used are listed in Table 3. E. coli strains were grown in Luria-Bertani (LB, Oxoid) medium, and S. epidermidis strains were grown in tryptic soy broth (TSB, Oxoid). When necessary, antibiotics were added: ampicillin (amp) 100 μg/ml, kanamycin (kan) 25 μg/ml, erythromycin (erm) 2.5 μg/ml. V. harveyi BB170 was grown in autoinducer bioassay (AB) medium at 30°C. For microarray experiments, overnight cultures of S. epidermidis (wild-type and luxS mutant) were 1:100 diluted into 50 ml of TSB and incubated at 37°C with shaking at 180 rpm until grown to mid-logarithmic growth phase. After addition of AI-2 to S. epidermidis 1457ΔluxS, incubation was continued for 1 h.
Table 3

Bacterial strains and plasmids used in this study

Strains/plasmids

Relevant genotype and property

Source/reference

S. epidermidis

  

1457

Wild-type strain

[38]

1457 ΔluxS

luxS mutant (luxS- ermr)

[24]

E. coli

  

XL1 blue

recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB lacIqZΔM15 Tn10 (Tetr)]

Qiagen

SG13009 [pREP4]

K12 derivative, Nals Strs Rifs Thi- Lac- Ara- Gal+ Mtl- F- RecA+ Uvr+ Lon+ [pREP4 KanR]

Qiagen

BL21

F-,omp T, hsd S(rB-, mB-), gal

Amersham

V. harveyi

  

BB170

luxN::Tn5(sensor-1- sensor-2+), AI-2 reporter strain

ATCC BAA-1117

Plasmids

  

pQE-9

lac Iq, 3.4 kb, Apr, T5, C-terminal 6 × His-tag

Qiagen

pQE-luxS

pQE-9 containing the luxS gene of S. epidermidis 1457

this study

pGEX-4T-1

lac Iq, 4.9 bp, Apr, GST gene fusion vector

Amersham

pGEX-pfs

pGEX-4T-1 containing the pfs gene of S. epidermidis 1457

this study

Overexpression and purification of LuxS and Pfs

The pfs gene was cloned and overexpressed as a glutathione-S-transferase (GST) fusion. The luxS gene was cloned and overexpressed as histidine residue-tagged (6 × His tag) fusion. Primers for amplification of pfs and luxS genes from S. epidermidis 1457 genomic DNA were as follows. For amplification of the pfs gene, the primers used were 5'-GCTTTATAAATGAGGTGTGAAAGGATCC ATGATAG-3' and 5'-CAATATCTTTTCACCTGAATTC TTATAATGATTCT-3'. For amplification of the luxS gene, the primers used were 5'-CAATAAGGAGGATGTCGAC ATGACTAAAATGAATG-3' and 5'-TTAGTTGTATTGTCTGCAG TTTACCTTCTCCGTAG-3'. PCR products were purified, digested using Bam HI and Eco RI for pfs and SaI I and Pst I for luxS. The pfs gene was cloned into the GST gene fusion vector pGEX-4T-1 (Amersham Biosciences), and the recombinant vector pGEX-pfs was maintained in E. coli strain BL21 (Amersham Biosciences) for overexpression. The luxS gene was cloned into the His-tag fusion vector pQE-9 (Qiagen), the recombinant vector pQE-luxS was transferred to E. coli strain XL1 blue (Qiagen) for propagating plasmids and then transferred to E. coli strain SG13009 [pREP4] (Qiagen) for overexpression. Unless otherwise noted, cultures of these two strains were grown at 37°C with aeration to an OD600 of 1.0. IPTG was added to a final concentration of 0.5 mM, the cultures were incubated with aeration for an additional 5 h, and cells were harvested. For recombinant Pfs, the fusion protein was purified using the GST-Tag purification Kit (Chemicon) according to the manufacturer's instructions. For recombinant LuxS, the fusion protein was purified on Ni-NTA agarose matrix columns by washing with 10 volumes of 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0, followed by elution with 5 volumes of 50 mM NaH2PO4, 300 mM NaCl, 100 mM imidazole, pH 8.0. The purified fusion proteins were concentrated in Centriprep-10 concentrators (Amicon) and dialysed against 10 mM sodium phosphate buffer (pH 7.5) using PD-10 Desalting columns (Amersham Biosciences). The sizes of the Pfs GST fusion protein and the LuxS His-tag fusion protein were confirmed by SDS-PAGE.

In vitro production of AI-2

Commercially available S-adenosylhomocysteine (SAH, Sigma) was used as the substrate for AI-2 synthesis [34]. In vitro AI-2 synthesis reactions were carried out at 37°C. SAH (1 mM) was incubated with 1 mg/ml purified Pfs in 10 mM sodium phosphate buffer (pH 7.5) for 1 h, and the reactions were filtered through Ultrafree-10 units (Amicon). Subsequently, 1 mg/ml purified LuxS in 10 mM sodium phosphate buffer (pH 7.5) was added, and the reaction mixture was incubated for another hour. After incubation, reactions were filtered through the same filters as described above to remove protein from the reaction product.

AI-2 bioassays

The AI-2 bioassay that uses the V. harveyi reporter strain BB170 was performed as described [35]. Briefly, the V. harveyi reporter strain was grown overnight at 30°C with aeration in AB medium, diluted 1:5000 into fresh AB medium, and 90 μl of the diluted cells were added to microtiter wells containing 10 μl of the samples to be tested for AI-2 activity. Sodium phosphate buffer (10 mM, pH 7.5) or medium alone was added as negative control. The microtiter dishes were shaken in a rotary shaker at 180 rpm at 30°C. Every hour, light production was measured using a Microlumatplus LB 96 V luminometer (Berthold). All assays were repeated at least three times.

S. epidermidis microarray experiments

Total RNA was isolated using an RNeasy Mini Kit (Qiagen) as recommended in a standard protocol. In brief, cell pellets were washed with RNase-free water, resuspended in 700 μl of RLT Buffer supplemented with β-mercaptoethanol (10 μl β-mercaptoethanol per 1 ml RLT). The bacterial suspension was transferred to a 2-ml FastPrep lysing tube (Q-BioGene). The cells were lysed in a Bio101 high-speed homogenizer (Savant Instruments), at the following setting: speed, 6.0; time, 20 s. The lysate was incubated on ice for 5 min and centrifuged at 15,000 rpm at 4°C for 15 min. The supernatant was collected and diluted with 500 μl of 100% ethanol. Samples were mixed and transferred to an RNeasy mini column. RNA isolation was performed according to the manufacturer's instructions. Remaining DNA was removed using RNase-free DNase I (Amersham Biosciences). Removal of contaminant DNA was confirmed by PCR. The reaction product was cleaned up with an RNeasy mini column. cDNA was synthesized and labeled according to the manufacturer's suggestions for Affymetrix antisense genome arrays (Affymetrix) as described [36]. A gel shift assay with NeutrAvidin (Pierce Biotechnology) was performed to estimate the labeling efficiency based on the instructions from Affymetrix. Biotinylated S. epidermidis cDNA was hybridized to custom Affymetrix GeneChips (RMLChip 3) with 98.9% coverage of genes from S. epidermidis RP62A (2467 probe sets of 2494 ORFs) and scanned according to standard GeneChip protocols (Affymetrix). Each experiment was replicated at least 3 times. Affymetrix GeneChip Operating Software GCOS v1.4 was used to perform the preliminary analysis of the custom chips at the probe-set level. Subsequent data analysis was performed as described [36]. To be included in the final gene list, gene expression must have been changed at least 2-fold for one of the treatments. The complete set of microarray data was deposited in NCBIs Gene Expression Omnibus [37] and is accessible through GEO Series accession number GSE9427.

Quantitative reverse-transcription (RT) polymerase chain reaction (PCR)

Oligonucleotide primers and probes (Tab. 4) were synthesized by Sigma. Probes for quantitative RT-PCR were used to continuously monitor formation of PCR products during PCR. cDNA was synthesized from total RNA using the SuperScript III first-strand synthesis system (Invitrogen) according to the manufacturer's instructions. The resulting cDNA and negative control samples were amplified with TaqMan Universal PCR Master Mix (Applied Biosystems). Reactions were performed in a MicroAmp Optical 96-well reaction plate using a 7700 Sequence Detector (Applied Biosystems). Standard curves were determined for each gene, by use of purified chromosomal template DNA at concentrations of 0.005–50 ng/ml. All RT-PCR experiments were performed in triplicate, with 16S RNA used as a control.
Table 4

Oligonucleotide primers and probes used for RT-PCR

Gene product

 

Oligonucleotide(5'-3')

Acetoin dehydrogenase

Forward

GAGCAAGCTAAAGAGGCTGGTTAT

 

Probe

CCTTGAAATGCTGATTGAGTCACTTTCACAT

 

Reverse

CCTTTGATTAACGCCTTTGCAT

Gluconokinase

Forward

AGTAAAACCAGGTGCAGAAGGATT

 

Probe

CGCGCTCTCCAGCTAAATAGGG

 

Reverse

CGTCAGCGTTCCACAATGG

Antiholin-like protein LrgB

Forward

TGTCGCGGCAGCTAAAGAA

 

Probe

ACTGCAATACTTCCCATTGATTCTTCAG

 

Reverse

CAACAATAACGCCAACGATGAC

Nitrite extrusion protein

Forward

GGTTGGTGGTGTTATAGGTGATAAATTT

 

Probe

AAGCGCTTATCATCGACTTCGTG

 

Reverse

GCTTAATATAAGCGCACCAATAATCAT

PTS system, fructose-specific IIABC components

Forward

TTAATCACAGCAAACAACTCTCACAT

 

Probe

CAATGAGTGATTTATCGAACACCATAT

 

Reverse

TCTTGTCATTGGTTCCTTGGTAATT

Detection and quantitation of PSMs in bacterial culture filtrates

High-pressure liquid chromatography – mass spectrometry (HPLC-MS) was used to detect and quantify PSMs in bacterial culture supernatants. One hundred-microliter samples from cultures were injected onto an analytical reversed-phase column (Zorbax C8, 2.1 × 30 mm; Agilent). A gradient from 0.1% trifluoroacetic acid (TFA) in 50% acetonitrile/50% water to 0.1% TFA in 90% acetonitrile/10% water was applied by use of an Agilent 1100 system connected to a VL trap mass spectrometer.

Declarations

Acknowledgements

This work was supported by the Intramural Program of the National Institute of Allergy and Infectious Diseases, NIH.

Authors’ Affiliations

(1)
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, The National Institutes of Health
(2)
Research Technologies Branch, Genomics Unit, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, The National Institutes of Health
(3)
Laboratory of Zoonotic Pathogens, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, The National Institutes of Health

References

  1. Camilli A, Bassler BL: Bacterial small-molecule signaling pathways. Science. 2006, 311 (5764): 1113-1116. 10.1126/science.1121357.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Surette MG, Miller MB, Bassler BL: Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A. 1999, 96 (4): 1639-1644. 10.1073/pnas.96.4.1639.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Winzer K, Hardie KR, Burgess N, Doherty N, Kirke D, Holden MT, Linforth R, Cornell KA, Taylor AJ, Hill PJ, Williams P: LuxS: its role in central metabolism and the in vitro synthesis of 4-hydroxy-5-methyl-3(2H)-furanone. Microbiology. 2002, 148 (Pt 4): 909-922.View ArticlePubMedGoogle Scholar
  4. Federle MJ, Bassler BL: Interspecies communication in bacteria. J Clin Invest. 2003, 112 (9): 1291-1299. 10.1172/JCI200320195.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Xavier KB, Bassler BL: LuxS quorum sensing: more than just a numbers game. Curr Opin Microbiol. 2003, 6 (2): 191-197. 10.1016/S1369-5274(03)00028-6.View ArticlePubMedGoogle Scholar
  6. Stroeher UH, Paton AW, Ogunniyi AD, Paton JC: Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse model. Infect Immun. 2003, 71 (6): 3206-3212. 10.1128/IAI.71.6.3206-3212.2003.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Anand SK, Griffiths MW: Quorum sensing and expression of virulence in Escherichia coli O157:H7. Int J Food Microbiol. 2003, 85 (1-2): 1-9. 10.1016/S0168-1605(02)00482-8.View ArticlePubMedGoogle Scholar
  8. Lyon WR, Madden JC, Levin JC, Stein JL, Caparon MG: Mutation of luxS affects growth and virulence factor expression in Streptococcus pyogenes. Mol Microbiol. 2001, 42 (1): 145-157. 10.1046/j.1365-2958.2001.02616.x.View ArticlePubMedGoogle Scholar
  9. Elvers KT, Park SF: Quorum sensing in Campylobacter jejuni: detection of a luxS encoded signalling molecule. Microbiology. 2002, 148 (Pt 5): 1475-1481.View ArticlePubMedGoogle Scholar
  10. McNab R, Ford SK, El-Sabaeny A, Barbieri B, Cook GS, Lamont RJ: LuxS-based signaling in Streptococcus gordonii: autoinducer 2 controls carbohydrate metabolism and biofilm formation with Porphyromonas gingivalis. J Bacteriol. 2003, 185 (1): 274-284. 10.1128/JB.185.1.274-284.2003.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Herzberg M, Kaye IK, Peti W, Wood TK: YdgG (TqsA) controls biofilm formation in Escherichia coli K-12 through autoinducer 2 transport. J Bacteriol. 2006, 188 (2): 587-598. 10.1128/JB.188.2.587-598.2006.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Auger S, Krin E, Aymerich S, Gohar M: Autoinducer 2 affects biofilm formation by Bacillus cereus. Appl Environ Microbiol. 2006, 72 (1): 937-941. 10.1128/AEM.72.1.937-941.2006.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Merritt J, Qi F, Goodman SD, Anderson MH, Shi W: Mutation of luxS affects biofilm formation in Streptococcus mutans. Infect Immun. 2003, 71 (4): 1972-1979. 10.1128/IAI.71.4.1972-1979.2003.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Balestrino D, Haagensen JA, Rich C, Forestier C: Characterization of type 2 quorum sensing in Klebsiella pneumoniae and relationship with biofilm formation. J Bacteriol. 2005, 187 (8): 2870-2880. 10.1128/JB.187.8.2870-2880.2005.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Vendeville A, Winzer K, Heurlier K, Tang CM, Hardie KR: Making 'sense' of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol. 2005, 3 (5): 383-396. 10.1038/nrmicro1146.View ArticlePubMedGoogle Scholar
  16. Lowery CA, McKenzie KM, Qi L, Meijler MM, Janda KD: Quorum sensing in Vibrio harveyi: probing the specificity of the LuxP binding site. Bioorg Med Chem Lett. 2005, 15 (9): 2395-2398. 10.1016/j.bmcl.2005.02.069.View ArticlePubMedGoogle Scholar
  17. Neiditch MB, Federle MJ, Miller ST, Bassler BL, Hughson FM: Regulation of LuxPQ receptor activity by the quorum-sensing signal autoinducer-2. Mol Cell. 2005, 18 (5): 507-518. 10.1016/j.molcel.2005.04.020.View ArticlePubMedGoogle Scholar
  18. Sun J, Daniel R, Wagner-Dobler I, Zeng AP: Is autoinducer-2 a universal signal for interspecies communication: a comparative genomic and phylogenetic analysis of the synthesis and signal transduction pathways. BMC Evol Biol. 2004, 4: 36-10.1186/1471-2148-4-36.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Taga ME, Miller ST, Bassler BL: Lsr-mediated transport and processing of AI-2 in Salmonella typhimurium. Mol Microbiol. 2003, 50 (4): 1411-1427. 10.1046/j.1365-2958.2003.03781.x.View ArticlePubMedGoogle Scholar
  20. Taga ME, Semmelhack JL, Bassler BL: The LuxS-dependent autoinducer AI-2 controls the expression of an ABC transporter that functions in AI-2 uptake in Salmonella typhimurium. Mol Microbiol. 2001, 42 (3): 777-793. 10.1046/j.1365-2958.2001.02669.x.View ArticlePubMedGoogle Scholar
  21. Vuong C, Otto M: Staphylococcus epidermidis infections. Microbes Infect. 2002, 4 (4): 481-489. 10.1016/S1286-4579(02)01563-0.View ArticlePubMedGoogle Scholar
  22. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M: Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis. 2003, 188 (5): 706-718. 10.1086/377239.View ArticlePubMedGoogle Scholar
  23. Vuong C, Gotz F, Otto M: Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun. 2000, 68 (3): 1048-1053. 10.1128/IAI.68.3.1048-1053.2000.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Xu L, Li H, Vuong C, Vadyvaloo V, Wang J, Yao Y, Otto M, Gao Q: Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect Immun. 2006, 74 (1): 488-496. 10.1128/IAI.74.1.488-496.2006.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Doherty N, Holden MT, Qazi SN, Williams P, Winzer K: Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. J Bacteriol. 2006, 188 (8): 2885-2897. 10.1128/JB.188.8.2885-2897.2006.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Kong KF, Vuong C, Otto M: Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol. 2006, 296 (2-3): 133-139. 10.1016/j.ijmm.2006.01.042.View ArticlePubMedGoogle Scholar
  27. Mehlin C, Headley CM, Klebanoff SJ: An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med. 1999, 189 (6): 907-918. 10.1084/jem.189.6.907.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Vuong C, Durr M, Carmody AB, Peschel A, Klebanoff SJ, Otto M: Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell Microbiol. 2004, 6 (8): 753-759. 10.1111/j.1462-5822.2004.00401.x.View ArticlePubMedGoogle Scholar
  29. Raad I, Alrahwan A, Rolston K: Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998, 26 (5): 1182-1187. 10.1086/520285.View ArticlePubMedGoogle Scholar
  30. Otto M: Virulence factors of the coagulase-negative staphylococci. Front Biosci. 2004, 9: 841-863. 10.2741/1295.View ArticlePubMedGoogle Scholar
  31. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, Deleo FR, Otto M: Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007, 13 (12): 1510-1514. 10.1038/nm1656.View ArticlePubMedGoogle Scholar
  32. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, Bayles KW: The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A. 2007, 104 (19): 8113-8118. 10.1073/pnas.0610226104.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Rice KC, Bayles KW: Death's toolbox: examining the molecular components of bacterial programmed cell death. Mol Microbiol. 2003, 50 (3): 729-738. 10.1046/j.1365-2958.2003.t01-1-03720.x.View ArticlePubMedGoogle Scholar
  34. Schauder S, Shokat K, Surette MG, Bassler BL: The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol. 2001, 41 (2): 463-476. 10.1046/j.1365-2958.2001.02532.x.View ArticlePubMedGoogle Scholar
  35. Bassler BL, Greenberg EP, Stevens AM: Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. J Bacteriol. 1997, 179 (12): 4043-4045.PubMed CentralPubMedGoogle Scholar
  36. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M: Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A. 2007, 104 (22): 9469-9474. 10.1073/pnas.0702159104.PubMed CentralView ArticlePubMedGoogle Scholar
  37. National Center for Biotechnology Information (NCBI): Gene Expression Omnibus (GEO). [http://www.ncbi.nlm.nih.gov/geo/]
  38. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R: Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun. 1994, 62 (8): 3244-3253.PubMed CentralPubMedGoogle Scholar

Copyright

© Li et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement